- In January 2021, Frontia GlutenEx was developed by Novozymes. It would assist wheat processors in improving gluten protein recovery while reducing energy use.
- In February 2021, Merck collaborated with BioNTech (Germany) to provide lipids for the Pfizer-BioNTech COVID-19 vaccine (BNT162b2)
- In January 2021, Merck bought AmpTec (Germany). The company expanded its product portfolio by developing and manufacturing mRNA for use in vaccinations, therapies, and diagnostics as a result of this purchase
Frequently Asked Questions
The market is segmented based on Segmentation, By Tool (Oligonucleotides and Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells, Chassis Organisms, Xeno-Nucleic Acids), Technology (Gene Synthesis, Genome Engineering, Sequencing, Bioinformatics, Cloning, Site-Directed Mutagenesis, Measurement and Modeling, Microfluids, Nanotechnology), Application (Medical Applications, Industrial Applications, Food and Agriculture, Environmental Applications), Products (Synthetic DNA, Synthetic Oligos, Synthetic Genes, Software Tools, Chassis Organisms, Synthetic Clones, Synthetic Cells) – Industry Trends and Forecast to 2032
.
The Global Synthetic Biology Market size was valued at USD 17.55 USD Billion in 2024.
The Global Synthetic Biology Market is projected to grow at a CAGR of 22.7% during the forecast period of 2025 to 2032.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
